HER2-positive Breast Cancer Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPriyanka Sharma

About this trial

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Eligibility criteria

Qualifiers

Stage I-IV HER2-positive breast cancer

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Locations

6
KUCC - Indian Creek66211, Overland ParkKansas, United States
KUCC - Overland Park66215, Overland ParkKansas, United States
KUCC - Briarcliff66205, WestwoodKansas, United States
KUCC - Olathe66205, WestwoodKansas, United States

Sponsors and collaborators

Priyanka Sharma

Lead sponsor

University of Kansas Medical Center

Sponsor institution